News | Breast Density | June 15, 2018

California Women In Favor of Extending State's Breast Density Inform Law

Survey results indicate law has encouraged improved communication between patients and providers about the effect of breast density and supplement screening options

California Women In Favor of Extending State's Breast Density Inform Law

June 15, 2018 — A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to extend beyond its current Jan. 1, 2019 expiration date. The survey, conducted by global nonprofit breast health organizations Are You Dense Inc. and Are You Dense Advocacy Inc., also found that nearly 75 percent of women know that dense breast tissue makes it more difficult to see cancer on a mammogram, suggesting the 2013 law has been effective in its aim.

Furthermore the vast majority of women with dense breast tissue have had conversations about it, including the discussion of additional screening with their physicians.

California State Senator Holly J. Mitchell, chair of the Senate Budget and Fiscal Review Committee, recently introduced bill SB1034 to eliminate the law’s “sunset” clause. The law set to end requires healthcare providers to disclose to patients their breast tissue density as part of mammography reporting results. Sen. Mitchell stated, “From my perspective, the more women know, the more we empower ourselves to be self-health advocates and understand the complexities of our own bodies so that we can have informed conversations with our doctors.”

Are Your Dense Inc. and Are You Dense Advocacy Inc. commissioned Spectrum Associates to determine California women’s awareness of the issue of dense breast tissue and law’s impact. An online survey through Research Now was distributed to 500 California women, between the ages of 40 and 74 years old who had a mammogram within the past two years. The surveys were completed March 22-27, 2018. The racial/ethnic representation within the study sample was reflective of the state’s population.

Other key findings from the survey include:

  • Eighty-five percent of respondents agreed that it is important that every woman knew her type of breast tissue;
  • Eighty-eight percent agreed that they would prefer to know than not know;
  • Sixty-eight percent of California women learned of their breast tissue type from a conversation with healthcare providers; and
  • Fifty-nine percent of the respondents who had dense breasts indicated that their healthcare provider had talked to them about having additional screening.

“It is critically important that the voices of women who participate in mammography screening are front and center as the merits of the breast density law are debated,” said Nancy M. Cappello, Ph.D., founder and executive director, Are You Dense Inc. and Are You Dense Advocacy Inc. “Furthermore, California women want the law to stay in place, as it is leading to conversations between patient and provider about personalized screening potentially resulting in early detection, an opportunity I never had.”

Cappello launched Are You Dense Inc. in 2008, shortly after learning that her late stage 3C breast cancer, which metastasized to 13 lymph nodes, was missed on mammography due to having dense breast tissue, which was never disclosed to her. According to Cappello, the medical community knew about the limitations of dense breasts to detect cancer on mammogram and its breast cancer risk.

Through her organizations, Cappello helped create the first state density reporting law in her home state of Connecticut in 2009.

Richard Reitherman, Ph.D., M.D., medical director of breast imaging at the Memorial Care Breast Center at Orange Coast Memorial, Fountain Valley, Calif., testified in support of SB1034. He added, "The California Dense Breast Notification law has served to motivate informed decision-making by validating every woman's right to know the scientific facts that may save her life by taking dominion over her personal healthcare decisions."

“The survey confirms that California women want information about their breast tissue density," noted Amy Colton, a nurse from Santa Cruz who recently testified at the Senate Hearing Committee. Colton advocated for the current California density reporting law after invasive cancer was hidden on mammography because of her dense breast tissue. “It validates their belief that patients have a right to know about their own physiology and that dense breasts present a risk and may influence the accuracy of screening. By removing the sunset date, women will continue to receive information regarding their breast density, its inherent risks and screening limitations.”

The final survey report and infographic can be read here.

For more information:

Related Breast Density Content

VIDEO: The Impact of Breast Density Technology and Legislation

VIDEO: Personalized Breast Screening and Breast Density

High-Risk Clinic Arms Patients Against Breast Cancer

VIDEO: Breast Imaging and Risk Assessment at Northwestern Medicine Central DuPage

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...